Purple Biotech Market Cap

Purple Biotech has a market cap or net worth of 22.43 million as of August 14, 2025. Its market cap has decreased by -51.91% in one year.

Market Cap

22.43M

Enterprise Value

2.98M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

3.70

Market Cap Chart

Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 22.43M, an increase of 25.46%. That is a compound annual growth rate of 1.89%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	22.43M	-44.40%
Dec 31, 2024	40.34M	-48.30%
Dec 31, 2023	78.02M	-17.30%
Dec 29, 2022	94.35M	-55.64%
Dec 30, 2021	212.71M	-1.36%
Dec 31, 2020	215.65M	332.51%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	64.35B
Danel (Adir Yeoshua)	2.50B
Kamada	1.43B
Bait Bakfar	1.06B
SofWave Medical	977.04M
BrainsWay	788.52M
Novolog (Pharm-Up 1966)	709.61M
Ilex Medical	673.41M

Market Cap Rankings